摘要 |
COMPOUNDS AND PHARMACEUTICALLY ACCEPTABLE SALTS OF THE COMPOUNDS ARE DISCLOSED, WHEREIN THE COMPOUNDS HAVE THE STRUCTURE OF FORMULA I: WHEREIN R2, R6A, R6B AND R8 ARE AS DEFINED IN THE SPECIFICATION. CORRESPONDING PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, SYNTHETIC METHODS, AND INTERMEDIATES ARE ALSO DISCLOSED. |
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
HUGHES, ROBERT O.;HEASLEY, STEVEN EDWARD;JACOBSEN, ERIC JON;MADDUX, TODD MICHAEL;MISCHKE, BRENT VIRGIL;MOLYNEAUX, JOHN MAJOR;MOON, JOSEPH BLAIR;ROGIER, JR., DONALD JOSEPH;TOLLEFSON, MICHAEL BRENT;WALKER, JOHN KEITH;BELL, ANDREW SIMON;BROWN, DAVID GRAHAM;OWEN, DAFYDD RHYS;PALMER, MICHAEL JOHN;PHILLIPS, CHRISTOPHER;BROWN, DAVID LOUIS;FOBIAN, YVETTE MARLENE;FRESKOS, JOHN NICHOLAS |